Innate and Adaptive Autoimmunity Directed to the Central Nervous System

被引:138
作者
Bhat, Roopa [1 ]
Steinman, Lawrence [1 ]
机构
[1] Stanford Univ, Beckman Ctr Mol Med, Stanford, CA 94305 USA
关键词
MYELIN BASIC-PROTEIN; MULTIPLE-SCLEROSIS LESIONS; EATON MYASTHENIC SYNDROME; GRAY-MATTER PATHOLOGY; WHITE-MATTER; HUMAN BRAIN; INFLAMMASOMES GUARDIANS; CEREBROSPINAL-FLUID; MOLECULAR-BASIS; T-CELLS;
D O I
10.1016/j.neuron.2009.09.015
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The immune system has two major components, an innate arm and an adaptive arm. Certain autoimmune diseases of the brain represent examples of disorders where one of these constituents plays a major role. Some rare autoimmune diseases involve activation of the innate arm and include chronic infantile neurologic, cutaneous, articular (CINCA) syndrome. In contrast, adaptive immunity is prominent in multiple sclerosis, neuromyelitis optica, and the paraneoplastic syndromes where highly specific T cell responses and antibodies mediate these diseases. Studies of autoimmune brain disorders have aided in the elucidation of distinct neuronal roles played by key molecules already well known to immunologists (e.g., complement and components of the major histocompatibility complex). In parallel, molecules known to neurobiology and sensory physiology, including toll-like receptors, gamma amino butyric acid and the lens protein alpha B crystallin, have intriguing and distinct functions in the immune system, where they modulate autoimmunity directed to the brain.
引用
收藏
页码:123 / 132
页数:10
相关论文
共 79 条
[71]   A molecular trio in relapse and remission in multiple sclerosis [J].
Steinman, Lawrence .
NATURE REVIEWS IMMUNOLOGY, 2009, 9 (06) :440-447
[72]   The classical complement cascade mediates CNS synapse elimination [J].
Stevens, Beth ;
Allen, Nicola J. ;
Vazquez, Luis E. ;
Howell, Gareth R. ;
Christopherson, Karen S. ;
Nouri, Navid ;
Micheva, Kristina D. ;
Mehalow, Adrienne K. ;
Huberman, Andrew D. ;
Stafford, Benjamin ;
Sher, Alexander ;
Litke, Alan M. ;
Lambris, John D. ;
Smith, Stephen J. ;
John, Simon W. M. ;
Barres, Ben A. .
CELL, 2007, 131 (06) :1164-1178
[73]  
Taiz L., 2018, FUNDAMENTALS PLANT P
[74]   Quantitative and qualitative changes in gene expression patterns characterize the activity of plaques in multiple sclerosis [J].
Tajouri, L ;
Mellick, AS ;
Ashton, KJ ;
Tannenberg, AEG ;
Nagra, RM ;
Tourtellotte, WW ;
Griffiths, LR .
MOLECULAR BRAIN RESEARCH, 2003, 119 (02) :170-183
[75]   Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis [J].
Tzartos, John S. ;
Friese, Manuel A. ;
Craner, Matthew J. ;
Palace, Jackie ;
Newcombe, Jia ;
Esiri, Margaret M. ;
Fugger, Lars .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (01) :146-155
[76]   THE PRODUCT OF THE TOBACCO MOSAIC-VIRUS RESISTANCE GENE-N - SIMILARITY TO TOLL AND THE INTERLEUKIN-1 RECEPTOR [J].
WHITHAM, S ;
DINESHKUMAR, SP ;
CHOI, D ;
HEHL, R ;
CORR, C ;
BAKER, B .
CELL, 1994, 78 (06) :1101-1115
[77]  
WILLIAMS AF, 1992, CR ACAD SCI III-VIE, V314, P27
[78]   Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients - Identity of key contact residues in the B-cell and T-cell epitopes [J].
Wucherpfennig, KW ;
Catz, I ;
Hausmann, S ;
Strominger, JL ;
Steinman, L ;
Warren, KG .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :1114-1122
[79]   Inflammation in Alzheimer disease: driving force, bystander or beneficial response? [J].
Wyss-Coray, Tony .
NATURE MEDICINE, 2006, 12 (09) :1005-1015